165 related articles for article (PubMed ID: 25666297)
61. [18F-FDG-PET-CT in soft tissue sarcomas: when to image?].
Rodríguez-Alfonso B; Mucientes Rasilla J; Mitjavila Casanovas M; Cardona Arboniés J; Cubedo R
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):43-9. PubMed ID: 24094372
[No Abstract] [Full Text] [Related]
62. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
63. Performance of FDG PET/ceCT in the evaluation of patients with lung cancer.
Nanni C; Rossetti V; Zompatori M; Ambrosini V; Montesi V; Mascherini D; Pettinato C; Marzola MC; Colletti PM; Rubello D; Fanti S
Biomed Pharmacother; 2014 Mar; 68(2):219-23. PubMed ID: 24486108
[TBL] [Abstract][Full Text] [Related]
64. [Proposal for a diagnostic algorithm for the use of (18)F-FDG-PET in lung cancer].
Borrego-Dorado I; Vázquez-Albertino R
Rev Esp Med Nucl; 2009; 28(3):167-72. PubMed ID: 19558959
[No Abstract] [Full Text] [Related]
65. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary.
Freudenberg LS; Fischer M; Antoch G; Jentzen W; Gutzeit A; Rosenbaum SJ; Bockisch A; Egelhof T
Med Princ Pract; 2005; 14(3):155-60. PubMed ID: 15863988
[TBL] [Abstract][Full Text] [Related]
66. Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study.
Schwenzer NF; Schraml C; Müller M; Brendle C; Sauter A; Spengler W; Pfannenberg AC; Claussen CD; Schmidt H
Radiology; 2012 Aug; 264(2):551-8. PubMed ID: 22653189
[TBL] [Abstract][Full Text] [Related]
67. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
[TBL] [Abstract][Full Text] [Related]
68. [18F-FDG PET-CT in a case of solitary plasmacytoma of the soft palate].
Fernández López R; Borrego Dorado I; Paz Coll A; Vázquez Albertino R; Gómez Camarero P; Sanz Viedma S
Rev Esp Med Nucl; 2010; 29(5):263-5. PubMed ID: 20663591
[TBL] [Abstract][Full Text] [Related]
69. Simultaneous visualization of FDG avid and non-avid metastases in renal cell cancer.
Yapar AF
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):357-8. PubMed ID: 23084019
[No Abstract] [Full Text] [Related]
70. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
71. Spectrum of gastric malignancy on 18F-FDG PET/CT: a pictorial essay.
Makis W; Ciarallo A; Hickeson M; Rush C; Derbekyan V; Novales-Diaz JA; Laufer J; Stern J; Lisbona R
Clin Imaging; 2012; 36(5):432-46. PubMed ID: 22920343
[TBL] [Abstract][Full Text] [Related]
72. FDG PET/CT in monitoring treatment of retroperitoneal fibrosis.
Yilmaz S; Tan YZ; Ozhan M; Halac M; Asa S; Sönmezoglu K
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):338-9. PubMed ID: 23084017
[TBL] [Abstract][Full Text] [Related]
73. PET/CT in non-small cell lung cancer staging-promises and problems.
Devaraj A; Cook GJ; Hansell DM
Clin Radiol; 2007 Feb; 62(2):97-108. PubMed ID: 17207691
[TBL] [Abstract][Full Text] [Related]
74. 18F-FDG PET/CT of Bronchial Mucous Gland Adenoma.
Cho J; Eo JS; In KH; Kim CH; Choe JG
Clin Nucl Med; 2016 Feb; 41(2):e118-9. PubMed ID: 26252327
[TBL] [Abstract][Full Text] [Related]
75. (18)F-FDG PET/CT scan in malignant priapism with diffuse pulmonary adenocarcinoma metastatic invasion of both corpus spongiosum and cavernosum.
Blanc E; Calais J; Cardot V; Mabille L
Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):588-9. PubMed ID: 24346413
[No Abstract] [Full Text] [Related]
76. Localized Airspace Consolidation of Pulmonary Alveolar Proteinosis Mimicking Malignant Lesions in 18F-FDG PET/CT Imaging: One Case Report.
Wang YL; Fang N; Zeng L; Wu ZJ; Cui XJ
Clin Nucl Med; 2015 Nov; 40(11):908-9. PubMed ID: 26252337
[TBL] [Abstract][Full Text] [Related]
77. Recent progress in positron emission tomography concerning diagnosis and treatment of lung cancer.
Nakamura H
Ann Thorac Cardiovasc Surg; 2012; 18(2):85-8. PubMed ID: 22523107
[No Abstract] [Full Text] [Related]
78. Effect of blind bone marrow biopsy on FDG-PET/CT interpretation of the posterior iliac crest in diffuse large B-cell lymphoma.
Adams HJ; de Klerk JM; Fijnheer R; Dubois SV; Nievelstein RA; Kwee TC
Hematol Oncol; 2016 Mar; 34(1):52-4. PubMed ID: 25308895
[No Abstract] [Full Text] [Related]
79. A rare case of pulmonary malignant granular cell tumor detected with 18F-FDG PET/CT imaging.
Cheng AP; Dong MJ; Fu LP; Zhao LJ; Wang XG; Sun WY
Clin Nucl Med; 2014 Sep; 39(9):816-8. PubMed ID: 24300348
[TBL] [Abstract][Full Text] [Related]
80. Fluorodeoxyglucose positron-emission tomography (FDG PET)/computed tomography (CT) in bladder cancer.
Goh V; Cook G
BJU Int; 2013 Oct; 112(6):709. PubMed ID: 24028759
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
